Some patients also have received prior cytotoxic therapy, either as adjuvant remedy or for metastatic illness.larotrectinib will boost the stage or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.Prevent or Use Alternate Drug. Prevent coadministration of sensitive CYP3A4 substrates with